Aggrenox and Peripheral vascular disorder - a phase IV clinical study of FDA data

Summary:

Peripheral vascular disorder is reported as a side effect among people who take Aggrenox (aspirin; dipyridamole), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Reglan, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Peripheral vascular disorder when taking Aggrenox. It is created by eHealthMe based on reports of 7,431 people who have side effects when taking Aggrenox from the FDA, and is updated regularly.

What is Aggrenox?

Aggrenox has active ingredients of aspirin; dipyridamole. It is often used in stroke. eHealthMe is studying from 7,654 Aggrenox users. Check the latest studies of Aggrenox.

What is Peripheral vascular disorder?

Peripheral vascular disorder is found to be associated with 785 drugs and 758 conditions by eHealthMe. Check the latest studies of Peripheral vascular disorder.

On Aug, 04, 2026

7,431 people reported to have side effects when taking Aggrenox.
Among them, 24 people (0.32%) have Peripheral vascular disorder.

Could Aggrenox cause Peripheral vascular disorder?

Among these 24 people:

How long have people been on Aggrenox when they have Peripheral vascular disorder? *

What is the gender of people who have Peripheral vascular disorder when taking Aggrenox? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Peripheral vascular disorder when taking Aggrenox? *

What are other drugs people take besides Aggrenox? *

What are other side effects people have besides Peripheral vascular disorder? *

Stress And Anxiety: 18 people, 75.00%
Depression: 17 people, 70.83%
High Blood Pressure: 16 people, 66.67%
Haemorrhage (bleeding): 15 people, 62.50%
Weakness: 14 people, 58.33%
Nausea (feeling of having an urge to vomit): 14 people, 58.33%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 14 people, 58.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 14 people, 58.33%
Atelectasis (partial or complete collapse of the lung): 12 people, 50.00%
Pneumonia: 12 people, 50.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 10 people, 41.67%
Osteoporosis (bones weak and more likely to break): 2 people, 8.33%
Diabetes: 2 people, 8.33%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 4.17%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 4.17%
Nausea (feeling of having an urge to vomit): 1 person, 4.17%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 4.17%
High Blood Pressure: 1 person, 4.17%
Depression: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Aggrenox and have Peripheral vascular disorder?

- Check whether Peripheral vascular disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aggrenox:

Aggrenox (7,654 reports)

Browse all side effects of Aggrenox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Peripheral vascular disorder:

Peripheral vascular disorder (785 drugs)

Browse all the conditions that are associated with Peripheral vascular disorder:

Peripheral vascular disorder (758 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aspirin; dipyridamole (the active ingredients of Aggrenox) and Aggrenox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.